PCDHGB7 inhibits the progression of triple‐negative breast cancer by suppressing XRCC5/MYC‐mediated ribosome biogenesis.

Saved in:
Bibliographic Details
Title: PCDHGB7 inhibits the progression of triple‐negative breast cancer by suppressing XRCC5/MYC‐mediated ribosome biogenesis.
Authors: Shan, Ming1 (AUTHOR), Bi, Hongjie2,3 (AUTHOR), Sun, Hua2 (AUTHOR), Li, Yixin2 (AUTHOR), Li, Zhiqi2 (AUTHOR), Wang, Ziyuan2 (AUTHOR), Dong, Jianguo2 (AUTHOR), Sang, Shengbo2 (AUTHOR), Ren, Lili2,3 (AUTHOR), Ye, Yuguang4 (AUTHOR), Wang, Tianzhen2 (AUTHOR), Volarević, Siniša5 (AUTHOR), Su, Rui3 (AUTHOR), Zhang, Lei2 (AUTHOR), Zhang, Minghui6 (AUTHOR) cfzhangminghui@163.com, He, Yan2 (AUTHOR) he_yan419@163.com, Zhang, Guoqiang1 (AUTHOR) zhangguoqiang@hrbmu.edu.cn, Li, Jing2 (AUTHOR) lijing2020@hrbmu.edu.cn, Li, Xiaobo1,2,7,8,9 (AUTHOR) lixiaobo@ems.hrbmu.edu.cn
Source: Clinical & Translational Medicine. Sep2025, Vol. 15 Issue 9, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20011326
DOI:10.1002/ctm2.70437